The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Revcovi (elapegademase-lvlr) is a new enzyme replacement therapy indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients.
Global Elapegademase-lvlr key players include Leadiant Biosciences, Teijin Pharma, Orchard Therapeutics, etc. Global top three manufacturers hold a share about 100%.
North America is the largest market, with a share about 45%, followed by Europe and Japan, both have a share about 45 percent.
In terms of product, Revcovi is the largest segment, with a share about 55%. And in terms of application, the largest application is Pediatric, followed by Adult.
The global Elapegademase-lvlr market was valued at US$ 14 million in 2020 and is expected to reach US$ 18 million by the end of 2027, growing at a CAGR of 3.6% during 2021-2027.
This report focuses on Elapegademase-lvlr volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Elapegademase-lvlr market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Elapegademase-lvlr Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Revcovi
Strimvelis
Adagen
Segment by Application
Pediatric
Adult
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Leadiant Biosciences
Orchard Therapeutics
Teijin Pharma
Revcovi (elapegademase-lvlr) is a new enzyme replacement therapy indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients.
Global Elapegademase-lvlr key players include Leadiant Biosciences, Teijin Pharma, Orchard Therapeutics, etc. Global top three manufacturers hold a share about 100%.
North America is the largest market, with a share about 45%, followed by Europe and Japan, both have a share about 45 percent.
In terms of product, Revcovi is the largest segment, with a share about 55%. And in terms of application, the largest application is Pediatric, followed by Adult.
The global Elapegademase-lvlr market was valued at US$ 14 million in 2020 and is expected to reach US$ 18 million by the end of 2027, growing at a CAGR of 3.6% during 2021-2027.
This report focuses on Elapegademase-lvlr volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Elapegademase-lvlr market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Elapegademase-lvlr Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Revcovi
Strimvelis
Adagen
Segment by Application
Pediatric
Adult
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Leadiant Biosciences
Orchard Therapeutics
Teijin Pharma
Index1 Elapegademase-lvlr Market Overview
1.1 Product Overview and Scope of Elapegademase-lvlr
1.2 Elapegademase-lvlr Segment by Type
1.2.1 Global Elapegademase-lvlr Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Revcovi
1.2.3 Strimvelis
1.2.4 Adagen
1.3 Elapegademase-lvlr Segment by Application
1.3.1 Global Elapegademase-lvlr Sales Comparison by Application: (2021-2027)
1.3.2 Pediatric
1.3.3 Adult
1.4 Global Elapegademase-lvlr Market Size Estimates and Forecasts
1.4.1 Global Elapegademase-lvlr Revenue 2016-2027
1.4.2 Global Elapegademase-lvlr Sales 2016-2027
1.4.3 Elapegademase-lvlr Market Size by Region: 2016 Versus 2021 Versus 2027
2 Elapegademase-lvlr Market Competition by Manufacturers
2.1 Global Elapegademase-lvlr Sales Market Share by Manufacturers (2016-2021)
2.2 Global Elapegademase-lvlr Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Elapegademase-lvlr Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Elapegademase-lvlr Manufacturing Sites, Area Served, Product Type
2.5 Elapegademase-lvlr Market Competitive Situation and Trends
2.5.1 Elapegademase-lvlr Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Elapegademase-lvlr Players Market Share by Revenue
2.5.3 Global Elapegademase-lvlr Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Elapegademase-lvlr Retrospective Market Scenario by Region
3.1 Global Elapegademase-lvlr Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Elapegademase-lvlr Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Elapegademase-lvlr Market Facts & Figures by Country
3.3.1 North America Elapegademase-lvlr Sales by Country
3.3.2 North America Elapegademase-lvlr Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Elapegademase-lvlr Market Facts & Figures by Country
3.4.1 Europe Elapegademase-lvlr Sales by Country
3.4.2 Europe Elapegademase-lvlr Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Elapegademase-lvlr Market Facts & Figures by Region
3.5.1 Asia Pacific Elapegademase-lvlr Sales by Region
3.5.2 Asia Pacific Elapegademase-lvlr Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Elapegademase-lvlr Market Facts & Figures by Country
3.6.1 Latin America Elapegademase-lvlr Sales by Country
3.6.2 Latin America Elapegademase-lvlr Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Elapegademase-lvlr Market Facts & Figures by Country
3.7.1 Middle East and Africa Elapegademase-lvlr Sales by Country
3.7.2 Middle East and Africa Elapegademase-lvlr Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Elapegademase-lvlr Historic Market Analysis by Type
4.1 Global Elapegademase-lvlr Sales Market Share by Type (2016-2021)
4.2 Global Elapegademase-lvlr Revenue Market Share by Type (2016-2021)
4.3 Global Elapegademase-lvlr Price by Type (2016-2021)
5 Global Elapegademase-lvlr Historic Market Analysis by Application
5.1 Global Elapegademase-lvlr Sales Market Share by Application (2016-2021)
5.2 Global Elapegademase-lvlr Revenue Market Share by Application (2016-2021)
5.3 Global Elapegademase-lvlr Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Leadiant Biosciences
6.1.1 Leadiant Biosciences Corporation Information
6.1.2 Leadiant Biosciences Description and Business Overview
6.1.3 Leadiant Biosciences Elapegademase-lvlr Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Leadiant Biosciences Elapegademase-lvlr Product Portfolio
6.1.5 Leadiant Biosciences Recent Developments/Updates
6.2 Orchard Therapeutics
6.2.1 Orchard Therapeutics Corporation Information
6.2.2 Orchard Therapeutics Description and Business Overview
6.2.3 Orchard Therapeutics Elapegademase-lvlr Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Orchard Therapeutics Elapegademase-lvlr Product Portfolio
6.2.5 Orchard Therapeutics Recent Developments/Updates
6.3 Teijin Pharma
6.3.1 Teijin Pharma Corporation Information
6.3.2 Teijin Pharma Description and Business Overview
6.3.3 Teijin Pharma Elapegademase-lvlr Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Teijin Pharma Elapegademase-lvlr Product Portfolio
6.3.5 Teijin Pharma Recent Developments/Updates
7 Elapegademase-lvlr Manufacturing Cost Analysis
7.1 Elapegademase-lvlr Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Elapegademase-lvlr
7.4 Elapegademase-lvlr Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Elapegademase-lvlr Distributors List
8.3 Elapegademase-lvlr Customers
9 Elapegademase-lvlr Market Dynamics
9.1 Elapegademase-lvlr Industry Trends
9.2 Elapegademase-lvlr Growth Drivers
9.3 Elapegademase-lvlr Market Challenges
9.4 Elapegademase-lvlr Market Restraints
10 Global Market Forecast
10.1 Elapegademase-lvlr Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Elapegademase-lvlr by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Elapegademase-lvlr by Type (2022-2027)
10.2 Elapegademase-lvlr Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Elapegademase-lvlr by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Elapegademase-lvlr by Application (2022-2027)
10.3 Elapegademase-lvlr Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Elapegademase-lvlr by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Elapegademase-lvlr by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Elapegademase-lvlr Sales (Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Elapegademase-lvlr Sales (Units) Comparison by Application (2021-2027)
Table 3. Global Elapegademase-lvlr Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Elapegademase-lvlr Covered in This Study
Table 5. Global Elapegademase-lvlr Sales (Units) of Key Manufacturers (2016-2021)
Table 6. Global Elapegademase-lvlr Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Elapegademase-lvlr Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Elapegademase-lvlr Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Elapegademase-lvlr Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Elapegademase-lvlr Manufacturing Sites and Area Served
Table 11. Manufacturers Elapegademase-lvlr Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Elapegademase-lvlr by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Elapegademase-lvlr as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Elapegademase-lvlr Sales by Region (2016-2021) & (Units)
Table 16. Global Elapegademase-lvlr Sales Market Share by Region (2016-2021)
Table 17. Global Elapegademase-lvlr Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Elapegademase-lvlr Sales by Country (2016-2021) & (Units)
Table 19. North America Elapegademase-lvlr Sales Market Share by Country (2016-2021)
Table 20. North America Elapegademase-lvlr Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Elapegademase-lvlr Revenue Market Share by Country (2016-2021)
Table 22. Europe Elapegademase-lvlr Sales by Country (2016-2021) & (Units)
Table 23. Europe Elapegademase-lvlr Sales Market Share by Country (2016-2021)
Table 24. Europe Elapegademase-lvlr Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Elapegademase-lvlr Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Elapegademase-lvlr Sales by Region (2016-2021) & (Units)
Table 27. Asia Pacific Elapegademase-lvlr Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Elapegademase-lvlr Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Elapegademase-lvlr Revenue Market Share by Region (2016-2021)
Table 30. Latin America Elapegademase-lvlr Sales by Country (2016-2021) & (Units)
Table 31. Latin America Elapegademase-lvlr Sales Market Share by Country (2016-2021)
Table 32. Latin America Elapegademase-lvlr Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Elapegademase-lvlr Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Elapegademase-lvlr Sales by Country (2016-2021) & (Units)
Table 35. Middle East and Africa Elapegademase-lvlr Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Elapegademase-lvlr Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Elapegademase-lvlr Revenue Market Share by Country (2016-2021)
Table 38. Global Elapegademase-lvlr Sales (Units) by Type (2016-2021)
Table 39. Global Elapegademase-lvlr Sales Market Share by Type (2016-2021)
Table 40. Global Elapegademase-lvlr Revenue (Million US$) by Type (2016-2021)
Table 41. Global Elapegademase-lvlr Revenue Share by Type (2016-2021)
Table 42. Global Elapegademase-lvlr Price (USD/Unit) by Type (2016-2021)
Table 43. Global Elapegademase-lvlr Sales (Units) by Application (2016-2021)
Table 44. Global Elapegademase-lvlr Sales Market Share by Application (2016-2021)
Table 45. Global Elapegademase-lvlr Revenue (Million US$) by Application (2016-2021)
Table 46. Global Elapegademase-lvlr Revenue Share by Application (2016-2021)
Table 47. Global Elapegademase-lvlr Price (USD/Unit) by Application (2016-2021)
Table 48. Leadiant Biosciences Corporation Information
Table 49. Leadiant Biosciences Description and Business Overview
Table 50. Leadiant Biosciences Elapegademase-lvlr Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Leadiant Biosciences Elapegademase-lvlr Product
Table 52. Leadiant Biosciences Recent Developments/Updates
Table 53. Orchard Therapeutics Corporation Information
Table 54. Orchard Therapeutics Description and Business Overview
Table 55. Orchard Therapeutics Elapegademase-lvlr Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Orchard Therapeutics Elapegademase-lvlr Product
Table 57. Orchard Therapeutics Recent Developments/Updates
Table 58. Teijin Pharma Corporation Information
Table 59. Teijin Pharma Description and Business Overview
Table 60. Teijin Pharma Elapegademase-lvlr Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Teijin Pharma Elapegademase-lvlr Product
Table 62. Teijin Pharma Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Elapegademase-lvlr Distributors List
Table 66. Elapegademase-lvlr Customers List
Table 67. Elapegademase-lvlr Market Trends
Table 68. Elapegademase-lvlr Growth Drivers
Table 69. Elapegademase-lvlr Market Challenges
Table 70. Elapegademase-lvlr Market Restraints
Table 71. Global Elapegademase-lvlr Sales Forecast by Type (2022-2027) & (Units)
Table 72. Global Elapegademase-lvlr Sales Market Share Forecast by Type (2022-2027)
Table 73. Global Elapegademase-lvlr Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 74. Global Elapegademase-lvlr Revenue Market Share Forecast by Type (2022-2027)
Table 75. Global Elapegademase-lvlr Sales Forecast by Application (2022-2027) & (Units)
Table 76. Global Elapegademase-lvlr Sales Market Share Forecast by Application (2022-2027)
Table 77. Global Elapegademase-lvlr Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 78. Global Elapegademase-lvlr Revenue Market Share Forecast by Application (2022-2027)
Table 79. Global Elapegademase-lvlr Sales Forecast by Region (2022-2027) & (Units)
Table 80. Global Elapegademase-lvlr Sales Market Share Forecast by Region (2022-2027)
Table 81. Global Elapegademase-lvlr Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 82. Global Elapegademase-lvlr Revenue Market Share Forecast by Region (2022-2027)
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Elapegademase-lvlr
Figure 2. Global Elapegademase-lvlr Market Share by Type in 2020 & 2027
Figure 3. Revcovi Product Picture
Figure 4. Strimvelis Product Picture
Figure 5. Adagen Product Picture
Figure 6. Global Elapegademase-lvlr Market Share by Application in 2020 & 2027
Figure 7. Pediatric
Figure 8. Adult
Figure 9. Global Elapegademase-lvlr Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Elapegademase-lvlr Market Size 2016-2027 (US$ Million)
Figure 11. Global Elapegademase-lvlr Sales 2016-2027 (Units)
Figure 12. Global Elapegademase-lvlr Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Elapegademase-lvlr Sales Share by Manufacturers in 2020
Figure 14. Global Elapegademase-lvlr Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Elapegademase-lvlr Players: Market Share by Revenue in 2020
Figure 16. Elapegademase-lvlr Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Elapegademase-lvlr Sales Market Share by Region (2016-2021)
Figure 18. Global Elapegademase-lvlr Sales Market Share by Region in 2020
Figure 19. Global Elapegademase-lvlr Revenue Market Share by Region (2016-2021)
Figure 20. Global Elapegademase-lvlr Revenue Market Share by Region in 2020
Figure 21. U.S. Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Elapegademase-lvlr Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Elapegademase-lvlr by Type (2016-2021)
Figure 46. Sales Market Share of Elapegademase-lvlr by Application (2016-2021)
Figure 47. Sales Market Share of Elapegademase-lvlr by Application in 2020
Figure 48. Revenue Share of Elapegademase-lvlr by Application (2016-2021)
Figure 49. Revenue Share of Elapegademase-lvlr by Application in 2020
Figure 50. Manufacturing Cost Structure of Elapegademase-lvlr
Figure 51. Manufacturing Process Analysis of Elapegademase-lvlr
Figure 52. Elapegademase-lvlr Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
